Medication interaction risk

Honey Packs and CYP3A4 Inhibitors: Interaction Risk

CYP3A4 inhibitors can raise sildenafil or tadalafil exposure. That matters for honey packs because FDA has found those drugs hidden in some products, and the amount is not listed on the label. A pharmacist or clinician should review the exact medication list.

Editorial review 2026-05-03 · FDA honey-products source current as of 2026-04-22

Why This Matters

The interaction risk is driven by what may be hidden in the packet, not by honey itself. FDA source records document honey-based products with sildenafil or tadalafil not listed on the label.

Severity
Serious - Increases drug levels
Interaction
Increased sildenafil/tadalafil blood levels, enhanced side effects, prolonged duration
Mechanism
Inhibition of hepatic metabolism (CYP3A4)

Examples

Ritonavir
Ketoconazole
Itraconazole
Clarithromycin
Erythromycin
Grapefruit juice

This list is not complete. Use it as a prompt for a pharmacist or clinician review, not as a clearance checklist.

Emergency Symptoms

  • ! Chest pain or pressure
  • ! Difficulty breathing
  • ! Severe dizziness or fainting
  • ! Erection lasting more than 4 hours
  • ! Irregular heartbeat
  • ! Sudden vision loss
  • ! Sudden hearing loss
  • ! Seizures
  • ! Signs of stroke (facial drooping, arm weakness, speech difficulty)

What To Do Next

  • • Ask a licensed pharmacist or clinician to review your exact medication and substance list.
  • • Use the interaction checker as a screening tool, not medical clearance.
  • • Keep the packet, UPC, lot number, seller, and time consumed if symptoms occur.
  • • Report adverse events to FDA MedWatch; call Poison Control for immediate exposure questions.